DEX/CRH test for psychiatric disorder

DEX/CRH test for psychiatric disorder - DEX/CRH test for psychiatric disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013214

Enrollment

100

Registered

2014-02-21

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression, bipolar disorder, schizophrenia

Interventions

DEX 1.5mg oral administration at 11PM on the previous day, CRH 100 micro gram injection at 2PM, then check the blood concentration of cortisol and ACTH.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Along with the ICD-10, F1, F2, F3, F4, F5, and G40.

Exclusion criteria

Exclusion criteria: forced admission patient

Design outcomes

Primary

Measure	Time frame
The sensitivity and specificity of DEX/CRH test for psychiatric disorder.	—

Countries

Japan

Contacts

Public ContactTetsufumi Kanazawa

Osaka Medical College Neuropsychiatry dept.

psy052@poh.osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026